S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
Lots of sound and fury on US debt, but not a crisis — yet
Italy's premier visits Libya for talks on energy, migration
Is This The End of Capitalism? (Ad)
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
Japan firm opens whale meat vending machines to push sales
The Next Big Crisis Is Here (Ad)
Online system to seek asylum in US is quickly overwhelmed
Flights canceled as UK airline Flybe sinks into bankruptcy
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
Lots of sound and fury on US debt, but not a crisis — yet
Italy's premier visits Libya for talks on energy, migration
Is This The End of Capitalism? (Ad)
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
Japan firm opens whale meat vending machines to push sales
The Next Big Crisis Is Here (Ad)
Online system to seek asylum in US is quickly overwhelmed
Flights canceled as UK airline Flybe sinks into bankruptcy
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
Lots of sound and fury on US debt, but not a crisis — yet
Italy's premier visits Libya for talks on energy, migration
Is This The End of Capitalism? (Ad)
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
Japan firm opens whale meat vending machines to push sales
The Next Big Crisis Is Here (Ad)
Online system to seek asylum in US is quickly overwhelmed
Flights canceled as UK airline Flybe sinks into bankruptcy
S&P 500   3,852.36
DOW   32,920.46
QQQ   296.26
Is Buying an Aged Corporation a Good Idea?
Is This The End of Capitalism? (Ad)
Lots of sound and fury on US debt, but not a crisis — yet
Italy's premier visits Libya for talks on energy, migration
Is This The End of Capitalism? (Ad)
Italy, Libya sign $8B gas deal as PM Meloni visits Tripoli
Japan firm opens whale meat vending machines to push sales
The Next Big Crisis Is Here (Ad)
Online system to seek asylum in US is quickly overwhelmed
Flights canceled as UK airline Flybe sinks into bankruptcy
NYSE:BSX

Boston Scientific - BSX Stock Forecast, Price & News

$45.91
-0.44 (-0.95%)
(As of 01/27/2023 12:00 AM ET)
Add
Compare
Today's Range
$45.74
$46.35
50-Day Range
$42.94
$47.20
52-Week Range
$34.98
$47.95
Volume
7.34 million shs
Average Volume
6.00 million shs
Market Capitalization
$65.76 billion
P/E Ratio
109.31
Dividend Yield
N/A
Price Target
$50.00

Boston Scientific MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.93 Rating Score
Upside/​Downside
8.9% Upside
$50.00 Price Target
Short Interest
Healthy
1.09% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-0.98
Upright™ Environmental Score
News Sentiment
0.28mentions of Boston Scientific in the last 14 days
Based on 16 Articles This Week
Insider Trading
Selling Shares
$9.56 M Sold Last Quarter
Proj. Earnings Growth
10.40%
From $1.73 to $1.91 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.17 out of 5 stars

Medical Sector

623rd out of 1,054 stocks

Surgical & Medical Instruments Industry

63rd out of 105 stocks


BSX stock logo

About Boston Scientific (NYSE:BSX) Stock

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Rhythm and Neuro, Cardiovascular and MedSurg. The Rhythm and Neuro segment develops implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities. The Cardiovascular segment consists of technologies for diagnosing and treating coronary artery disease and other cardiovascular disorders including structural heart conditions. The MedSurg segment focuses on Endoscopy, which provides devices to diagnose and treat a broad range of gastrointestinal and pulmonary conditions with innovative and invasive technologies. The company was founded by John E. Abele and Pete Michael Nicholas on June 29, 1979, and is headquartered in Marlborough, MA.

Receive BSX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter.

BSX Stock News Headlines

Is Medtronic Stock Ready to Revive? (BSX)
The world’s largest medical device maker Medtronic PLC (NYSE: MDT) stock has fallen since April 2022. However, shares may have bottomed out.
Boston Scientific (NYSE:BSX) Upgraded by StockNews.com to Buy
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Here's Why You Should Retain Boston Scientific (BSX) Now
The Next Big Crisis Is Here
You just can’t see it yet because it’s NOT a banking, financial, or economic crisis… it’s far worse and threatens every dollar in your retirement account.
Boston Bruins vs. San Jose Sharks odds, tips and betting trends
See More Headlines
Receive BSX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Boston Scientific and its competitors with MarketBeat's FREE daily newsletter.

BSX Company Calendar

Last Earnings
10/26/2021
Today
1/28/2023
Next Earnings (Confirmed)
2/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
Health Care Equipment
Sector
Medical
CUSIP
10113710
Employees
41,000
Year Founded
1979

Price Target and Rating

Average Stock Price Forecast
$50.00
High Stock Price Forecast
$56.00
Low Stock Price Forecast
$43.00
Forecasted Upside/Downside
+8.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.93
Research Coverage
15 Analysts

Profitability

Net Income
$1.04 billion
Pretax Margin
6.88%

Debt

Sales & Book Value

Annual Sales
$11.89 billion
Cash Flow
$2.68 per share
Book Value
$11.66 per share

Miscellaneous

Outstanding Shares
1,432,310,000
Free Float
1,422,142,000
Market Cap
$65.76 billion
Optionable
Optionable
Beta
0.83

Social Links


Key Executives

  • Michael F. MahoneyMichael F. Mahoney
    Chairman, President & Chief Executive Officer
  • Edward F. MackeyEdward F. Mackey
    Executive Vice President-Global Operations
  • Daniel J. BrennanDaniel J. Brennan
    Chief Financial Officer & Executive Vice President
  • Jodi Eddy
    Senior VP, Chief Information & Digital Officer
  • Ian T. MeredithIan T. Meredith
    Global Chief Medical Officer & Executive VP













BSX Stock - Frequently Asked Questions

Should I buy or sell Boston Scientific stock right now?

15 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Boston Scientific in the last twelve months. There are currently 2 hold ratings, 12 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" BSX shares.
View BSX analyst ratings
or view top-rated stocks.

What is Boston Scientific's stock price forecast for 2023?

15 Wall Street research analysts have issued twelve-month price targets for Boston Scientific's shares. Their BSX share price forecasts range from $43.00 to $56.00. On average, they expect the company's share price to reach $50.00 in the next twelve months. This suggests a possible upside of 8.9% from the stock's current price.
View analysts price targets for BSX
or view top-rated stocks among Wall Street analysts.

How have BSX shares performed in 2023?

Boston Scientific's stock was trading at $46.27 on January 1st, 2023. Since then, BSX shares have decreased by 0.8% and is now trading at $45.91.
View the best growth stocks for 2023 here
.

Are investors shorting Boston Scientific?

Boston Scientific saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 15,610,000 shares, an increase of 10.6% from the December 31st total of 14,110,000 shares. Based on an average daily trading volume, of 6,830,000 shares, the days-to-cover ratio is presently 2.3 days.
View Boston Scientific's Short Interest
.

When is Boston Scientific's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 1st 2023.
View our BSX earnings forecast
.

How can I listen to Boston Scientific's earnings call?

Boston Scientific will be holding an earnings conference call on Wednesday, February 1st at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

How were Boston Scientific's earnings last quarter?

Boston Scientific Co. (NYSE:BSX) released its earnings results on Tuesday, October, 26th. The medical equipment provider reported $0.41 earnings per share for the quarter, beating analysts' consensus estimates of $0.40 by $0.01. The medical equipment provider had revenue of $2.93 billion for the quarter, compared to analyst estimates of $2.97 billion. Boston Scientific had a trailing twelve-month return on equity of 14.55% and a net margin of 5.19%. The firm's revenue for the quarter was up 10.3% compared to the same quarter last year. During the same quarter last year, the firm earned $0.37 EPS.
Read the conference call transcript
.

What guidance has Boston Scientific issued on next quarter's earnings?

Boston Scientific updated its fourth quarter 2022 earnings guidance on Wednesday, November, 2nd. The company provided earnings per share (EPS) guidance of $0.45-$0.48 for the period, compared to the consensus EPS estimate of $0.49. The company issued revenue guidance of $3.19 billion-$3.25 billion, compared to the consensus revenue estimate of $3.32 billion.

What is Michael F. Mahoney's approval rating as Boston Scientific's CEO?

947 employees have rated Boston Scientific Chief Executive Officer Michael F. Mahoney on Glassdoor.com. Michael F. Mahoney has an approval rating of 98% among the company's employees. This puts Michael F. Mahoney in the top 20% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Boston Scientific own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Boston Scientific investors own include NVIDIA (NVDA), Alibaba Group (BABA), Intel (INTC), AT&T (T), CVS Health (CVS), Walt Disney (DIS), Bank of America (BAC), Advanced Micro Devices (AMD), Visa (V) and Salesforce (CRM).

What is Boston Scientific's stock symbol?

Boston Scientific trades on the New York Stock Exchange (NYSE) under the ticker symbol "BSX."

Who are Boston Scientific's major shareholders?

Boston Scientific's stock is owned by a variety of retail and institutional investors. Top institutional investors include Allspring Global Investments Holdings LLC (0.31%), Assenagon Asset Management S.A. (0.17%), New York State Teachers Retirement System (0.11%), Strs Ohio (0.08%), Natixis Advisors L.P. (0.07%) and Gateway Investment Advisers LLC (0.05%). Insiders that own company stock include Arthur C Butcher, Daniel J Brennan, David A Pierce, David A Pierce, David S Wichmann, Edward F Mackey, Eric Francis Yves Thepaut, Ian T Meredith, Jeffrey B Mirviss, Jeffrey B Mirviss, Jodi Euerle Eddy, John Bradley Sorenson, Jonathan Monson, Joseph Michael Fitzgerald, Maulik Nanavaty, Meghan Scanlon, Michael F Mahoney, Michael F Mahoney, Nelda J Connors, Scott Olson, Wendy Carruthers and William F Bruss.
View institutional ownership trends
.

How do I buy shares of Boston Scientific?

Shares of BSX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Boston Scientific's stock price today?

One share of BSX stock can currently be purchased for approximately $45.91.

How much money does Boston Scientific make?

Boston Scientific (NYSE:BSX) has a market capitalization of $65.76 billion and generates $11.89 billion in revenue each year. The medical equipment provider earns $1.04 billion in net income (profit) each year or $0.42 on an earnings per share basis.

How many employees does Boston Scientific have?

The company employs 41,000 workers across the globe.

Does Boston Scientific have any subsidiaries?
The following companies are subsidiares of Boston Scientific: 34 Biomedical Merger Corp., 9357-1867 Quebec Inc., Acurate Industria e Comercio Ltda., Advanced Bionics, Advanced Stent Technologies, American Medical Systems, American Medical Systems Europe B.V., Apama Medical, Apama Medical Inc., Asthmatx, Atritech, Augmenix, Augmenix Inc., Augmenix K.K., BSC International Medical Trading (Shanghai) Co. Ltd., BSC Medical Device Technology (Shanghai) Co. Ltd., BTG, BTG Australasia Pty Ltd, BTG Europe B.V., BTG IM Holdings Ltd., BTG International (Holdings) Limited, BTG International Asia Limited, BTG International Canada Inc., BTG International Germany GmbH, BTG International Healthcare Inc., BTG International Healthcare LLC, BTG International Healthcare Limited, BTG International Inc., BTG International Limited, BTG Limited, BTG Management Services Limited, BTG Medikal Limited Sirketi, Bard Electrophysiology, Barosense, Biocompatibles Inc., Biocompatibles International Limited, Biocompatibles UK Limited, Boston Scientific (Malaysia) Sdn. Bhd., Boston Scientific (South Africa) Proprietary Limited, Boston Scientific (Thailand) Ltd., Boston Scientific (UK) Limited, Boston Scientific AG, Boston Scientific Argentina S.A., Boston Scientific Asia Pacific Pte. Ltd., Boston Scientific Benelux NV, Boston Scientific Canada Limited, Boston Scientific Ceska republika s.r.o., Boston Scientific Chile SpA, Boston Scientific Colombia Limitada, Boston Scientific Comercial de Costa Rica BSCR S.R.L., Boston Scientific Far East B.V., Boston Scientific Gesellschaft m.b.H., Boston Scientific Group plc, Boston Scientific Hellas S.A., Boston Scientific Hong Kong Limited, Boston Scientific Iberica S.A., Boston Scientific India Private Limited, Boston Scientific International B.V., Boston Scientific International Finance Limited, Boston Scientific International S.A., Boston Scientific Israel Ltd., Boston Scientific Japan K.K., Boston Scientific Korea Co. Ltd., Boston Scientific Lebanon SAL, Boston Scientific Limited, Boston Scientific Ltd., Boston Scientific Medical Device, Boston Scientific Medical Device Limited, Boston Scientific Medizintechnik GmbH, Boston Scientific Middle East FZ-LLC, Boston Scientific Middle East SAL, Boston Scientific Nederland B.V., Boston Scientific Neuromodulation Corporation, Boston Scientific New Zealand Limited, Boston Scientific Nordic AB, Boston Scientific Peru S.A.C., Boston Scientific Philippines Inc., Boston Scientific Polska Sp. z o.o., Boston Scientific Portugal - Dispositivos Medicos Lda, Boston Scientific Pty Ltd, Boston Scientific Romania S.R.L., Boston Scientific S.A.S., Boston Scientific S.p.A., Boston Scientific Scimed, Boston Scientific Scimed Inc., Boston Scientific Services Private Limited, Boston Scientific TIP Gerecleri Limited Sirketi, Boston Scientific Technology & Engineering Services Private Limited, Boston Scientific Uruguay S.A., Boston Scientific Vietnam Company Limited, Boston Scientific de Costa Rica S.R.L., Boston Scientific de Mexico S.A. de C.V., Boston Scientific del Caribe Inc., Boston Scientific do Brasil Ltda., Bravo Bidco Limited, BridgePoint Medical, Cameron Health, Cardiac Pacemakers Inc., Cardiac Pathways Corp, Catheter Innovations, Claret Medical, Claret Medical Inc., Cosman Medical, Cosman Medical LLC, CryoCor, Cryterion Medical, Cryterion Medical Inc., Cryterion Medical Ireland Limited, EKOS LLC, EMcision, EMcision International Inc., EP Technologies, EP Technologies Inc., Electron Acquisition Corporation, EndoChoice, EndoChoice Holdings Inc., EndoChoice Inc., EndoChoice Innovation Center Ltd., EndoChoice Israel Ltd., Endotex, Enteric Medical Technologies, Galil Medical Inc., Galil Medical Ltd., Galil Medical UK Limited, Guidant, Guidant Delaware Holding Corporation, Guidant Europe NV, Guidant Puerto Rico B.V., Hong Kong Medtech Trading Limited, Intelect Medical, Millipede, Millipede Inc., NXT Merger Corp., Notebook Merger Sub Ltd., Novate Medical Limited, NxThera, NxThera Inc., PT Boston Scientific Indonesia, PneumRx GmbH, PneumRx LLC, PneumRx Liimited, Protherics Medicines Development B.V., Protherics Medicines Development Limited, Protherics UK Limited, Provensis Limited, RMI Acquisition Corp., Remon Medical Technologies, Rhythmia Medical, Robert S. Smith M.D. Inc., Roxwood Medical Inc., SNS Merger Corp, Sadra Medical, Sadra Medical Inc., Securus Medical Group, Securus Medical Group Inc., Special K Merger Corp., StarMedTec, Stream Enterprises LLC, Symetis, Symetis SA, Target Therapeutics, Target Therapeutics Inc., The LumenR Tissue Retractor System, Veniti, Veniti Inc., VertiFlex, Vertiflex Inc., Vessix Vascular, Xlumena, Zuma Investment Pty Ltd, iogyn, nVision Medical, and nVision Medical Corporation.
Read More
How can I contact Boston Scientific?

Boston Scientific's mailing address is 300 BOSTON SCIENTIFIC WAY, MARLBOROUGH MA, 01752. The official website for the company is www.bostonscientific.com. The medical equipment provider can be reached via phone at (508) 683-4000, via email at bsxinvestorrelations@bsci.com, or via fax at 508-683-5675.

This page (NYSE:BSX) was last updated on 1/29/2023 by MarketBeat.com Staff